Current treatment strategies for newly diagnosed heart failure patients.

1 May 2017 (12:50 - 13:10)

Organised by:

About the speaker

Professor Christian Veltmann

Heart Center Bremen, Bremen (Germany)

4 More presentations in this session

Presentation thumbnail

Introduction - The wearable cardioverter defibrillator: an essential tool in the management of patients at high risk for sudden cardiac death.

Doctor T. Helms (Hamburg, DE)

Presentation thumbnail

Screening: a systematic and efficient way to optimize patient selection at risk for sudden cardiac death.

Professor J. Sperzel (Bad Nauheim, DE)

Presentation thumbnail

Utility of remotely managed patient clinical and diagnostic markers to effect better outcomes.

Professor S. Stoerk (Wuerzburg, DE)

Presentation thumbnail

Panel discussion and summary.

Professor C. Leclercq (Rennes, FR)

Access the full session

Session thumbnail

The wearable cardioverter defibrillator: an essential tool in the management of patients at high risk for sudden cardiac death

The Event

Heart Failure 2017 - 4th World Congress on Acute Heart Failure

1 May 2017 12:50 CET

You may be interested in

Webinar

How to implement new heart failure therapies in clinical practice

1 December 2022

Congress Presentation

Clinical characteristics of newly diagnosed vs. chronic heart failure patients in Spain: SEC-Excelente registry results.

31 August 2025

Congress Presentation

New foundational therapy in heart failure with reduced ejection fraction: a real-world experience and the need for changing guidelines

29 June 2021

Congress Session

When to consider device therapy in HFrEF

20 May 2025

ESC 365 is supported by

novartis

Explore sponsored resources

novo-nordisk

Explore sponsored resources

ESC 365 is supported by

novartis

Explore sponsored resources

novo-nordisk

Explore sponsored resources